Drug Interactions in the Treatment of Patients with Parkinson’s Disease - LimitingFactor of Successful Treatment
Lékové interakce při léčběparkinsoniků - limitující faktorúspěšné léčby
Přehledný článek uvádí možné interakce mezi léky užívanými k léčbě parkinsoniků (např.preparáty L-Dopa, neuroleptika apod.) a uvádí také řadu nevhodných léčebných kombinací.
Klíčová slova:
Parkinsonova nemoc - terapie - interakce léků - L-Dopa - neuroleptika.
Authors:
J. Fiedler
Authors‘ workplace:
Neurologická klinika FN, Plzeň, přednosta prof. MUDr. Z. Ambler, DrSc.
Published in:
Prakt. Lék. 1999; (2): 96-97
Category:
Overview
The submitted review deals with possible interactions between drugs used for treatment ofpatients with Parkinson’s disease (e.g. L-Dopa, neuroleptic drugs etc.) and the author mentionsalso some unsuitable therapeutic combinations.
Key words:
Parkinson’s disease - therapy - drug interactions - L-Dopa - neuroleptics.
Labels
General practitioner for children and adolescents General practitioner for adultsArticle was published in
General Practitioner
1999 Issue 2
- Hope Awakens with Early Diagnosis of Parkinson's Disease Based on Skin Odor
- Metamizole vs. Tramadol in Postoperative Analgesia
- Memantine in Dementia Therapy – Current Findings and Possible Future Applications
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
- Memantine Eases Daily Life for Patients and Caregivers
Most read in this issue
- Systemic Complications in Acute Yersiniosis
- Electroconvulsive Treatment - Pitfalls of Administration inExtreme Age Groups
- Prevention of Atherosclerosis from the Aspect of the Geneticist
- Economics of the Health Services. III. Introduction to Microeconomics ofthe Health Services